Skip to main content
    G

    Grace Therapeutics, Inc. (GRCE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.95
    +0.06 (+3.17%)

    Market Cap: $39.76M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    63%(19/30)
    Avg Surprise
    -34.16%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.21
    Range$-0.21 - $-0.21
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.20-1.5%
    60d ago$-0.20-1.5%
    30d ago$-0.18-13.0%
    7d ago$-0.18-13.0%
    Current$-0.21
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.21
    Range$-0.21 - $-0.21
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.20-1.5%
    60d ago$-0.20-1.5%
    30d ago$-0.18-13.0%
    7d ago$-0.18-13.0%
    Current$-0.21
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$-0.16---
    Dec 26EST
    		-$-0.21---
    Sep 26EST
    		-$-0.21---
    Jun 26
    Reported Aug 13
    		$-0.91$-0.18-405.56%Miss-213.8%
    Mar 26
    Reported Jun 18
    		$-0.08N/A+60.00%Beat-260.0%
    Dec 25
    Reported Feb 12
    		$-0.19N/A+51.28%Beat+62.9%
    Sep 25
    Reported Nov 13
    		$-0.08N/A+76.47%Beat+80.9%
    Jun 25
    Reported Aug 12
    		$-0.29$-0.31+6.45%Beat+12.1%
    Mar 25
    Reported Jun 23
    		$0.05N/A+112.55%Beat+114.0%
    Dec 24
    Reported Feb 13
    		$-0.51$-0.46-11.67%Miss-82.8%
    Sep 24
    Reported Nov 13
    		$-0.42$-0.50+16.79%Beat-34.9%
    Jun 24
    Reported Aug 9
    		$-0.33$-0.36+8.33%Beat+31.2%
    Mar 24
    Reported Jun 21
    		$-0.36$-0.47+24.13%Beat+45.1%
    Dec 23
    Reported Feb 12
    		$-0.28$-0.31+9.68%Beat+61.1%
    Sep 23
    Reported Nov 13
    		$-0.31$-0.35+11.43%Beat-181.8%
    Jun 23
    Reported Aug 11
    		$-0.48$-0.37-29.73%Miss-380.0%
    Mar 23
    Reported Jun 23
    		$-0.65$-0.14-364.29%Miss-109.7%
    Dec 22
    Reported Feb 14
    		$-0.72$-1.01+28.71%Beat-4.3%
    Sep 22
    Reported Nov 14
    		$-0.11N/AN/ABeat-266.7%
    Jun 22
    Reported Aug 11
    		$-0.10N/AN/ABeat-25.0%
    Mar 22
    Reported Jun 21
    		$-0.31N/A+69.00%Beat-29.2%
    Dec 21
    Reported Feb 14
    		$-0.69$-0.62-11.29%Miss+62.3%
    Sep 21
    Reported Nov 10
    		$-0.03N/AN/ABeat+99.2%
    Jun 21
    Reported Aug 12
    		$-0.08N/AN/ABeat+97.5%
    Mar 21
    Reported Jun 22
    		$-0.24$-0.04-500.00%Miss-209.1%
    Dec 20
    Reported Feb 9
    		$-1.83$-2.50+26.80%Beat+78.8%
    Sep 20
    Reported Nov 16
    		$-3.77$-3.17-18.93%Miss+76.9%
    Jun 20
    Reported Aug 13
    		$-3.17$-3.89+18.51%Beat+56.0%
    Mar 20
    Reported Jun 29
    		$0.22$-0.09+344.44%Beat+1064.9%
    Dec 19
    Reported Feb 14
    		$-8.64$-4.59-88.24%Miss-157.1%
    Sep 19
    Reported Nov 13
    		$-16.32$-5.28-209.09%Miss+45.2%
    Jun 19
    Reported Aug 14
    		$-7.20$-8.09+11.00%Beat+34.8%
    Mar 19
    Reported Jun 26
    		$-0.02N/A+79.27%Beat+99.8%
    Dec 18
    Reported Feb 14
    		$-3.36$-4.80+30.00%Beat+82.5%
    Sep 18
    Reported Nov 14
    		$-29.76$-6.72-342.86%Miss-154.1%
    Jun 18
    Reported Aug 14
    		$-11.04$-12.96+14.81%Beat-63.7%
    Mar 18
    Reported Jun 29
    		$-12.14N/AN/ABeat-49.9%
    Dec 17
    Reported Mar 31
    		$-19.20$-13.44-42.86%Miss-
    Sep 17
    Reported Nov 14
    		$-11.71N/AN/ABeat-
    Jun 17
    Reported Aug 15
    		$-6.74N/AN/ABeat-
    Dec 16
    Reported Jan 13
    		$-8.10N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-1.55EV/EBITDAN/A
    Price/FCF-3.27xFCF Yield-30.59%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-36.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio11.47xQuick Ratio11.47x
    Trading Statistics
    Beta0.33Avg Volume100.19K
    52-Week High$5.1852-Week Low$1.79

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.03
    SMA 20$2.07
    SMA 50$2.12
    SMA 200$2.91
    EMA 10$2.01
    EMA 20$2.06
    EMA 50$2.14
    EMA 200$2.60

    MACD

    Line: -0.05Signal: -0.03Hist: -0.02

    ADX

    ADX: 16.2+DI: 11.8-DI: 25.6

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down96.0
    PSAR$2.34

    Bollinger Bands

    Upper Band$2.21
    Lower Band$1.93
    %B Position1326%(Upper)
    Band Width0.06

    RSI (14-Day)

    Neutral
    38.7

    Momentum Oscillators

    Stoch %K19.6
    Stoch %D20.7
    Williams %R-66.9
    ROC (10d)-4.4%
    Momentum-0.09
    CCI (20d)-171.9
    MFI (14d)31.6

    Volatility Measures

    ATR (14d)$0.09(4.7%)
    StdDev (20d)0.07
    Hist Vol36.8%(Moderate)

    Volume Flow

    VWAP$1.94
    OBV-11.0M
    AD Line-9.8M
    CMF (20d)0.009

    Volume Metrics

    Avg Vol (20d)103.2K
    Vol Ratio1.1x
    VWMA (20d)$2.06

    Pivot Points

    R3$2.15
    R2$2.08
    R1$1.98
    Pivot Point$1.92
    S1$1.82
    S2$1.75
    S3$1.66

    Advanced Oscillators

    TSI-18.32
    Ultimate Osc49.2
    KST-55.13

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$8,000$0$0$0$0$0$0
    Cost of RevenueN/A$2,000$4,116$2,000$2,000$2,000$2,000$2,000$1,000$1,000$1,000$2,000
    Gross ProfitN/A$-2,000$-4,116$-2,000$-2,000$-2,000$-2,000$-2,000$-1,000$-1,000$-1,000$-2,000
    Operating Expenses$15.79M$3.01M$3.36M$3.53M$3.09M$4.53M$5.33M$4.83M$6.79M$4.43M$4.03M$2.83M
    R&D$697,000$420,000$633,924$792,206$955,000$2.33M$3.16M$2.98M$3.70M$2.29M$1.91M$622,945
    SG&A$1.69M$308,589$2.72M$2.73M$2.13M$2.20M$2.17M$1.85M$3.08M$2.01M$2.08M$2.21M
    Operating Income$-15,790,000$-3,010,000$-3,360,346$-3,527,272$-3,090,000$-4,532,942$-5,326,685$-4,831,000$-6,787,547$-4,427,923$-4,033,474$-2,833,049
    Interest Income$141,000$138,000$170,000$172,000$205,000$167,000$138,000$172,000$235,000$249,000$316,000$212,000
    Interest Expense$0$0$0$0$272,000$0$0$0$0$1.07M$0$2.20M
    Income Before Tax$-15,790,000$-2,878,000$-3,176,480$-1,308,256$-3,362,000$-544,010$0$-4,284,000$-4,569,251$-5,502,675$-3,444,955$-5,036,381
    Income Tax Expense$0$-1,700,000$0$0$0$-1,449,743$-870,044$-852,000$-990,164$-1,206,381$-275,702$-603,986
    Net Income$-15,790,000$-1,178,000$-3,176,480$-1,308,256$-3,362,000$905,733$-5,975,263$-3,432,000$-3,579,087$-4,296,293$-3,169,253$-4,432,394
    EBITDA$-15,788,000$-3,008,000$-3,357,346$-3,526,272$-3,088,000$-4,530,093$-5,323,809$-4,829,000$-6,786,180$-4,380,428$-4,032,149N/A
    EBIT$-15,790,000$-3,010,000$-3,360,346$-3,527,272$-3,090,000$-4,532,941$-5,326,685$-4,831,000$-6,787,547$-4,427,923$-4,033,474N/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GRCE

    News

    No news available

    Company news will appear here when available

    GRCE Valuation and Fair Value

    P/E
    -1.5x
    Forward P/E
    2.2x
    P/FCF
    -3.3x
    P/B
    0.7x
    See GNG's fair value

    GRCE Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -36.2%
    FCF yield
    -30.6%

    GRCE Competitors

    CompanyTicker
    Nano X Imaging LtdNNOX
    Scynexis IncSCYX
    Instil Bio Inc.TIL
    CVRx IncCVRX
    Precipio IncPRPO
    FibroGen IncFGEN
    Ekso Bionics Holdings IncEKSO
    Cosmos Health Inc.COSM

    Sector: Healthcare

    GRCE Bull Case vs Bear Case

    Bull case

    • GRCE beat EPS estimates in 75.0% of its last 8 reported quarters.

    GRCE Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -11.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.21
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About GRCE

    Does GRCE pay dividends?

    Grace Therapeutics, Inc. (GRCE) does not currently pay a regular dividend.

    What is GRCE's market cap?

    Grace Therapeutics, Inc. (GRCE) has a market capitalization of $39.76M with a current stock price of $1.95.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In